“Life sciences” is a common name of a raft of sciences dealing with living organisms and various types of life processes. The life sciences industry can be divided into several sub-groups such as Biotech & Pharma, healthcare, medical devices, research and lab services. Pharmaceuticals form the largest market sector; its sales are predicted to override USD 1 trillion by 2015.
The life sciences market proved to be rather resistant to unfavorable economic conditions. It has experienced healthy growth over the recent years on the back of the population increase, ongoing technological advancements and rising awareness of healthcare. Drug discovery, medical equipment and regenerative medicine represent the most promising market sectors.
A wealthy collection of the research reports providing extensive overview of the life sciences market is at hand in this MarketPublishers’ catalogue. Current situation and historic development of the market are reviewed in the researches. The reports thoroughly examine market segments, disclose essential information on the market size and characterize the industry dynamics and identify major forces shaping the market. Moreover, the long-term and short-term future outlooks for the market can be found in the research reports.
Publications found:
253,269
Sort by:
LAG 3 Next Generation Immunotherapy Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major LAG 3 next generation immunotherapy markets reached a value of US$ 370.1 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 4,403.0 Million by 2034, exhibiting a gr...
May 2024
129 pages
Langerhans Cell Histiocytosis Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The Langerhans cell histiocytosis market reached a value of US$ 406.7 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 683.9...
May 2024
134 pages
Lenegre’s Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major Lenegre’s disease markets reached a value of US$ 782.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,569.6 Million by 2034, exhibiting a growth rate (CAGR) o...
May 2024
140 pages
Lyme Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The Lyme disease market reached a value of US$ 594.1 Million across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 1,181.7 Mill...
May 2024
133 pages
Lymphedema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The 7 major lymphedema markets reached a value of US$ 647.9 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,405.7 Million by 2034, exhibiting a growth rate (CAGR) of 7.3%...
May 2024
133 pages
Macular Edema Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034
US$ 6,499.00
The Macular Edema market reached a value of US$ 3.5 Billion across the top 7 markets (US, EU4, UK, and Japan) in 2023. Looking forward, IMARC Group expects the top 7 markets to reach US$ 5.8 Billion b...
May 2024
132 pages
